Skip to content

Nightmares and psychiatric symptoms: A systematic review of longitudinal, experimental, and clinical trial studies.

Bryony Sheaves, Stephanie Rek, Daniel K. Freeman

Clinical Psychology Review December 17, 2022 DOI: 10.1016/j.cpr.2022.102241 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Systematic review Longitudinal Peer reviewed
Topics Anxiety Depression PTSD Dreaming
Keywords Humans Dreams Anxiety disorders Stress disorders, post-traumatic Suicidal ideation Suicide Psychosis Nightmares
Key findings The authors argue that the limited literature suggests treating nightmares may be one route to lessening threat-based disorders in particular, suggestive of a causal relationship. Treating nightmares led to moderate reductions in PTSD and depression, small to moderate reductions in anxiety, and potentially moderate reductions in paranoia; nightmares increased risk of later suicide outcomes, though two small pilot trials indicated treating nightmares might potentially prevent recovery of suicidal ideation.

Abstract

Nightmares occur across a wide range of psychiatric disorders, but outside of PTSD presentations are infrequently considered a treatment priority. We aimed to assess evidence for a contributory causal role of nightmares to the occurrence of psychiatric disorders, and vice versa. A systematic review was conducted of longitudinal, experimental, and clinical trial studies. Twenty-four longitudinal, sixteen trials, and no experimental studies were identified. Methodological shortcomings were common, especially the use of single-item nightmare assessment. Thirty-five studies assessed the path from nightmares to psychiatric symptoms. Depression (n = 10 studies), PTSD (n = 10) and anxiety (n = 5) were the most commonly assessed outcomes in trials. Most were not designed to assess the effect of nightmare treatment on psychiatric symptoms. Treating nightmares led to moderate reductions in PTSD and depression, small to moderate reductions in anxiety, and potentially moderate reductions in paranoia. Nightmares increased the risk of later suicide outcomes (n = 10), but two small pilot trials indicated that treating nightmares might potentially prevent recovery of suicidal ideation. PTSD treatment led to large reductions in trauma-related nightmares (n = 3). The limited literature suggests that treating nightmares may be one route to lessening threat-based disorders in particular, suggestive of a causal relationship. Overall, however, nightmares in most disorders are greatly understudied.

Comparable studies

Other systematic reviews and meta-analyses on dreaming, most cited first.

Study Year Design Participants
Dreaming as mind wandering: evidence from functional neuroimaging and first-person content reports. 2013 Systematic review with meta-analytic comparison
Lucid dreaming incidence: A quality effects meta-analysis of 50 years of research 2016 Meta-analysis
The effectiveness of lucid dreaming therapy in patients with nightmares: A systematic review. Adults with chronic and recurring nightmares 2023 Systematic review
The relationships between insomnia, nightmares, and dreams: A systematic review Individuals without a concomitant psychopathology, including those with insomnia or... 2024 Systematic review
Psychosocial treatments for nightmares in adults and children: a systematic review 2023 Systematic review

Citations in the library

Explore topics